Regeneron Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2019
Total Assets: $14.81B
Liabilities Breakdown FY2019
Total Liabilities: $3.72B
Asset Breakdown
Total Assets: $14.81B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.62B | 10.9% |
| Accounts Receivable | $2.10B | 14.2% |
| Inventory | $1.42B | 9.6% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $9.67B | 65.3% |
Liabilities Breakdown
Total Liabilities: $3.72B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $418.1M | 11.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $3.30B | 88.7% |